Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 10/20 | 0.40 |
| ▸ | CNR1 | P21554 | 10/20 | 0.40 |
| ▸ | HRH2 | P25021 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838287 | 0.97 | MAPT (0.43) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL4570248 | 0.97 | MAPT (0.43) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL16687522 | 0.96 | MAPT (0.43) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL838460 | 0.92 | MAPT (0.50) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL19442755 | 0.91 | MAPT (0.39) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL16746639 | 0.89 | MAPT (0.48) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL838090 | 0.89 | MAPT (0.55) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL4570247 | 0.89 | MAPT (0.48) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL13182760 | 0.88 | MAPT (0.47) | MAPTSMN1; SMN2CNR2CNR1HRH2 | |
| SCHEMBL13427328 | 0.88 | MAPT (0.47) | MAPTSMN1; SMN2CNR2CNR1HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7531582-B2 | Radiation curable phase change inks containing curable epoxy-polyamide composite gellants | XEROX CORPORATION (US) | 2009-05-12 | — | — | US | disclosed |
| US-20080122914-A1 | RADIATION CURABLE PHASE CHANGE INKS CONTAINING CURABLE EPOXY-POLYAMIDE COMPOSITE GELLANTS | XEROX CORPORATION (US) | 2008-05-29 | — | — | US | disclosed |